| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |